Unibio USA ApS: Financial statements 2018
CVR: 38179845
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Unibio USA ApS (CVR 38179845) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -15,000 and a net result of DKK -12,000. Equity in the 2018 report amounted to DKK 31,000. The solvency ratio was 73.8%.
- Gross Profit
- DKK -15,000
- Profit/Loss
- DKK -12,000
- Equity
- DKK 31,000
- Total Assets
- DKK 42,000
- Employees
- 0
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of June 15, 2018, Jakob Brix Christensen is registered as director of Unibio USA ApS.
As of June 15, 2018, Jesper Halling Pedersen has stepped down as director of Unibio USA ApS.
Unibio USA ApS has published its interim report for the period November 14, 2016 to December 31, 2017.
About Unibio USA ApS
Unibio USA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of David Richard Henstrom and Søren Olrik Eklund. The company is owned by UNIBIO A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK -20,000 compared with DKK -26,000 the year before. Equity in the 2025 report amounted to DKK 25,000.